Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statement of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Revenue related party $ 3,333
General and Administrative expenses 6,584 20,183 29,488 48,187
Professional Fees 18,105 14,777 55,710 105,005
Salaries and Wages 31,718 72,760 122,548 213,005
General and Administrative expenses - related party 30,000 30,000 90,000 90,000
Total Operating Expenses 86,407 137,720 297,746 456,197
Loss from Operations (86,407) (137,720) (297,746) (452,864)
Other Income and Expenses        
Unrealized Gain (Loss) on available for sale purchases (110,000) (72,000) 18,000 (29,500)
Net Loss allocated from Equity Method Investee (22,220) (3,000) (71,455) (50,791)
Interest expense (includes amortization of warrants on note) (52,267) (39,446) (153,965) (114,881)
Total Other Expenses (184,487) (114,446) (207,420) (195,172)
Net Loss (270,894) (252,166) (505,166) (648,036)
Net Income (Loss) attributable to Non Controlling Interest (1,775) 297 (5,325) (2,247)
Net Income (Loss) attributable to the company $ (269,119) $ (252,463) $ (499,841) $ (645,789)
Net Loss per share Basic and Diluted $ (0.01) $ (0.01) $ (0.02) $ (0.03)
Weighted average Number of Common Shares Outstanding-Basic and Diluted 21,674,000 21,620,000 21,674,000 21,620,000